Clinical Trials
2 trialsNCT03467308 2020-05-11
Signaling Pathways Targeting Colorectal Cancer in Egypt
Assiut University
Completed
NCT00393029 2011-08-15
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes
National Institutes of Health Clinical Center (CC)
Phase 2 Completed